Quarterly report pursuant to Section 13 or 15(d)

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)

v3.24.2.u1
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
ACCOUNTS PAYABLE AND ACCRUED EXPENSES    
Accrued research and development $ 2,976,379 $ 2,263,934
Accrued professional fees 124,096 58,388
Accrued compensation expenses 42,308 716,307
Other accounts payable and accrued expenses 10,134 3,809
Total $ 3,152,917 $ 3,042,438